A biobank for pediatric kidney tumors plays a key role in identifying hereditary causes of Wilms tumors. New insights gained with its help enable better risk assessment for affected families and could ...

Blood vessels are like big-city highways; full of curves, branches, merges, and congestion. Yet for years, lab models ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Bispecific anti-PD1/VEGF remains one of the hottest topics in the oncology field. Click here for a detailed analysis.

Obesity is not just a cosmetic issue—it is a clinical and biological risk factor and progression driver for ovarian cancer ...

Researchers found that the Wnt5a protein, secreted by inflammatory fibroblasts within cancerous tumors, inhibits angiogenesis and consequently promotes hypoxia within tumors. Hypoxic conditions help ...

After a blood test during her annual physical uncovered low hemoglobin levels, she underwent numerous tests and learned she had Stage 3 colorectal cancer. “They found a softball- and golf ball ...

From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...

Researchers still do not have a comprehensive picture of the factors that influence gene expression in human cancers.

Under terms of the deal, Pfizer will gain rights to develop, manufacture, and commercialize SSGJ-707 outside of China.

US pharma major Pfizer (NYSE: PFE) is stepping up its presence in the high-stakes field of bispecific immuno-oncology with a ...

University of Texas at Dallas bioengineers, in collaboration with UT Southwestern Medical Center researchers, are developing an enhanced light-activated immunotherapy approach that could one day treat ...